Environmental factors in causing human cancers: Emphasis on tumorigenesis

Tumor Biology

Volumn 33, Issue 5, 2012, Pages 1265-1274

  Sankpal, Umesh T ^a   Pius, Hima ^a,b   Khan, Moeez ^a,c   Shukoor, Mohammed I ^a   Maliakal, Pius ^a,b   Lee, Chris M ^a   Abdelrahim, Maen ^a,d   Connelly, Sarah F ^a   Basha, Riyaz ^a,b,c  

^a M D ANDERSON CANCER CENTER ORLANDO   (United States)

^b FLORIDA STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

^d TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

Carcinogenesis; Environmental factors; Nicotine; Polycyclic aromatic hydrocarbons

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; AMMONIA; AROMATIC AMINE; BENZENE DERIVATIVE; CARBON MONOXIDE; CARCINOGEN; CHLOROFORM; FORMALDEHYDE; METAL DERIVATIVE; MYCOTOXIN; NICOTINE DERIVATIVE; NITROSAMINE; ORGANOCHLORINE DERIVATIVE; PESTICIDE; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; POLYVINYLCHLORIDE; TAR; VOLATILE ORGANIC COMPOUND;

CARCINOGENICITY; CHEMICAL CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; ERGOTISM; HEALTH HAZARD; HUMAN; LIFESTYLE; MALIGNANT NEOPLASTIC DISEASE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SMOKING HABIT; TOBACCO;

EID: 84868145919     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-012-0413-4     Document Type: Review

References (111)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Printz C. Research continues into best ways to treat low-risk prostate cancer. Cancer. 2009;115:4431-2.
3. Hecht SS. Cigarette smoking: cancer risks, carcinogens, and mechanisms. Langenbecks Arch Surg. 2006;391:603-13.
4. Maneckjee R, Minna JD. Opioids induce while nicotine suppresses apoptosis in human lung cancer cells. Cell Growth Differ. 1994;5:1033-40.
5. Hecht SS, Hochalter JB, Villalta PW, Murphy SE. 2′-hydroxylation of nicotine by cytochrome p450 2a6 and human liver microsomes: formation of a lung carcinogen precursor. Proc Natl Acad Sci USA. 2000;97:12493-7.
6. Miller YE. Pathogenesis of lung cancer: 100 year report. Am J Respir Cell Mol Biol. 2005;33:216-23.
7. Philip M, Rowley DA, Schreiber H. Inflammation as a tumor promoter in cancer induction. Semin Cancer Biol. 2004;14:433-9.
8. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006;56:106-30.
9. Bey EA, Bentle MS, Reinicke KE, Dong Y, Yang CR, Girard L, et al. An nqo1- and parp-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone. Proc Natl Acad Sci USA. 2007;104:11832-7.
10. Albert JM, Cao C, Kim KW, Willey CD, Geng L, Xiao D, et al. Inhibition of poly(adp-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res. 2007;13:3033-42.
11. Minna JD. Nicotine exposure and bronchial epithelial cell nicotinic acetylcholine receptor expression in the pathogenesis of lung cancer. J Clin Invest. 2003;111:31-3.
12. Dasgupta P, Kinkade R, Joshi B, Decook C, Haura E, Chellappan S. Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating xiap and survivin. Proc Natl Acad Sci USA. 2006;103:6332-7.
13. Ozlu T, Bulbul Y. Smoking and lung cancer. Tuberk Toraks. 2005;53:200-9.
14. Chen J, Jiang R, Garces YI, Jatoi A, Stoddard SM, Sun Z, et al. Prognostic factors for limited-stage small cell lung cancer: a study of 284 patients. Lung Cancer. 2009;67(2):221-6.
15. Ebbert JO, Williams BA, Sun Z, Aubry MC, Wampfler JA, Garces YI, et al. Duration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women. Lung Cancer. 2005;47:165-72.
16. Ebbert JO, Yang P, Vachon CM, Vierkant RA, Cerhan JR, Folsom AR, et al. Lung cancer risk reduction after smoking cessation: observations from a prospective cohort of women. J Clin Oncol. 2003;21:921-6.
17. Walker MS, Vidrine DJ, Gritz ER, Larsen RJ, Yan Y, Govindan R, et al. Smoking relapse during the first year after treatment for early-stage non-small-cell lung cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2370-7.
18. Thomas P, Rubinstein L. Cancer recurrence after resection: T1 n0 non-small cell lung cancer. Lung cancer study group. Ann Thorac Surg. 1990;49:242-6. discussion 246-247.
19. Tsurutani J, Castillo SS, Brognard J, Granville CA, Zhang C, Gills JJ, et al. Tobacco components stimulate AKT-dependent proliferation and NFKAPPAB-dependent survival in lung cancer cells. Carcinogenesis. 2005;26:1182-95.
20. Browman GP, Wong G, Hodson I, Sathya J, Russell R, McAlpine L, et al. Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med. 1993;328:159-63.
21. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck Jr BE, Ihde DC, et al. Smoking abstinence and small cell lung cancer survival. An association. JAMA. 1980;244:2175-9.
22. Videtic GM, Stitt LW, Dar AR, Kocha WI, Tomiak AT, Truong PT, et al. Continued cigarette smoking by patients receiving concurrent chemoradiotherapy for limited-stage small-cell lung cancer is associated with decreased survival. J Clin Oncol. 2003;21:1544-9.
23. Schuller HM, Plummer 3rd HK, Jull BA. Receptor-mediated effects of nicotine and its nitrosated derivative NNK on pulmonary neuroendocrine cells. Anat Rec A Discov Mol Cell Evol Biol. 2003;270:51-8.
24. West KA, Brognard J, Clark AS, Linnoila IR, Yang X, Swain SM, et al. Rapid AKT activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. J Clin Invest. 2003;111:81-90.
25. West KA, Linnoila IR, Belinsky SA, Harris CC, Dennis PA. Tobacco carcinogen-induced cellular transformation increases activation of the phosphatidylinositol 3′-kinase/AKT pathway in vitro and in vivo. Cancer Res. 2004;64:446-51.
26. West KA, Linnoila IR, Brognard J, Belinsky S, Harris C, Dennis PA. Tobacco carcinogen-induced cellular transformation increases AKT activation in vitro and in vivo. Chest. 2004;125:101S-2S.
27. Ye YN, Liu ES, Shin VY, Wu WK, Luo JC, Cho CH. Nicotine promoted colon cancer growth via epidermal growth factor receptor, C-SRC, and 5-lipoxygenase-mediated signal pathway. J Pharmacol Exp Ther. 2004;308:66-72.
28. Dasgupta P, Rizwani W, Pillai S, Kinkade R, Kovacs M, Rastogi S, et al. Nicotine induces cell proliferation, invasion and epithelial-mesenchymal transition in a variety of human cancer cell lines. Int J Cancer. 2009;124:36-45.
29. Dasgupta P, Chellappan SP. Nicotine-mediated cell proliferation and angiogenesis: new twists to an old story. Cell Cycle. 2006;5:2324-8.
30. Davis R, Rizwani W, Banerjee S, Kovacs M, Haura E, Coppola D, et al. Nicotine promotes tumor growth and metastasis in mouse models of lung cancer. PLoS One. 2009;4:e7524.
31. Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489-501.
32. Dasgupta P, Rastogi S, Pillai S, Ordonez-Ercan D, Morris M, Haura E, et al. Nicotine induces cell proliferation by beta-arrestin-mediated activation of SRC and RB-RAF-1 pathways. J Clin Invest. 2006;116:2208-17.
33. Mazza R, Lina M, Boffi R, Invernizzi G, De Marco C, Pierotti M. Taking care of smoker patients: a review and some recommendations. Annals of Oncology. 2010;21(7):1404-9.
34. Cook MB, Kamangar F, Whiteman DC, Freedman ND, Gammon MD, Bernstein L, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the International Beacon Consortium. J Natl Cancer Inst. 2010;102:1344-53.
35. Shitara K, Matsuo K, Hatooka S, Ura T, Takahari D, Yokota T, et al. Heavy smoking history interacts with chemoradiotherapy for esophageal cancer prognosis: a retrospective study. Cancer Sci. 2010;101:1001-6.
36. Kogevinas M. Human health effects of dioxins: cancer, reproductive and endocrine system effects. Hum Reprod Update. 2001;7:331-9.
37. IARC working group on the evaluation of carcinogenic risks to humans. Polychlorinated dibenzo-para-dioxins and polychlorinated dibenzofurans. Lyon, France, 4-11 February 1997. IARC Monogr Eval Carcinog Risks Hum. 1997;69:1-631.
38. Giri AK. Mutagenic and genotoxic effects of 2,3,7,8-tetrachlorodibenzo-p- dioxin, a review. Mutat Res. 1986;168:241-8.
39. Huff JE, Salmon AG, Hooper NK, Zeise L. Long-term carcinogenesis studies on 2,3,7,8-tetrachlorodibenzo-p-dioxin and hexachlorodibenzo-p-dioxins. Cell Biol Toxicol. 1991;7:67-94.
40. Knerr S, Schrenk D. Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p- dioxin in experimental models. Mol Nutr Food Res. 2006;50:897-907.
41. Michalek JE, Tripathi RC. Pharmacokinetics of TCDD in veterans of operation ranch hand: 15-year follow-up. J Toxicol Environ Health A. 1999;57:369-78.
42. Jenkins S, Rowell C, Wang J, Lamartiniere CA. Prenatal TCDD exposure predisposes for mammary cancer in rats. Reprod Toxicol. 2007;23:391-6.
43. Floret N, Mauny F, Challier B, Cahn JY, Tourneux F, Viel JF. Dioxin emissions and soft-tissue sarcoma: results of a population-based case-control study. Rev Epidemiol Sante Publique. 2004;52:213-20.
44. Viel JF, Arveux P, Baverel J, Cahn JY. Soft-tissue sarcoma and non-Hodgkin's lymphoma clusters around a municipal solid waste incinerator with high dioxin emission levels. Am J Epidemiol. 2000;152:13-9.
45. Denison MS, Pandini A, Nagy SR, Baldwin EP, Bonati L. Ligand binding and activation of the ah receptor. Chem Biol Interact. 2002;141:3-24.
46. Carver LA, Bradfield CA. Ligand-dependent interaction of the aryl hydrocarbon receptor with a novel immunophilin homolog in vivo. J Biol Chem. 1997;272:11452-6.
47. Chen HS, Perdew GH. Subunit composition of the heteromeric cytosolic aryl hydrocarbon receptor complex. J Biol Chem. 1994;269:27554-8.
48. Baccarelli A, Pesatori AC, Masten SA, Patterson Jr DG, Needham LL, Mocarelli P, et al. Aryl-hydrocarbon receptor-dependent pathway and toxic effects of TCDD in humans: a population-based study in Seveso, Italy. Toxicol Lett. 2004;149:287-93.
49. Geter DR, Chang LW, Hanley NM, Ross MK, Pegram RA, DeAngelo AB. Analysis of in vivo and in vitro DNA strand breaks from trihalomethane exposure. J Carcinog. 2004;3:2.
50. Villanueva CM, Fernandez F, Malats N, Grimalt JO, Kogevinas M. Meta-analysis of studies on individual consumption of chlorinated drinking water and bladder cancer. J Epidemiol Community Health. 2003;57:166-73.
51. Cantor KP, Lynch CF, Hildesheim ME, Dosemeci M, Lubin J, Alavanja M, et al. Drinking water source and chlorination byproducts. I. Risk of bladder cancer. Epidemiology. 1998;9:21-8.
52. Hildesheim ME, Cantor KP, Lynch CF, Dosemeci M, Lubin J, Alavanja M, et al. Drinking water source and chlorination byproducts. II. Risk of colon and rectal cancers. Epidemiology. 1998;9:29-35.
53. Kasim K, Levallois P, Johnson KC, Abdous B, Auger P. Chlorination disinfection by-products in drinking water and the risk of adult leukemia in Canada. Am J Epidemiol. 2006;163:116-26.
54. King WD, Marrett LD, Woolcott CG. Case-control study of colon and rectal cancers and chlorination by-products in treated water. Cancer Epidemiol Biomarkers Prev. 2000;9:813-8.
55. Lioy PJ, Greenberg A. Factors associated with human exposures to polycyclic aromatic hydrocarbons. Toxicol Ind Health. 1990;6:209-23.
56. Waldman JM, Lioy PJ, Greenberg A, Butler JP. Analysis of human exposure to benzo(a)pyrene via inhalation and food ingestion in the total human environmental exposure study (THEES). J Expo Anal Environ Epidemiol. 1991;1:193-225.
57. Boffetta P, Jourenkova N, Gustavsson P. Cancer risk from occupational and environmental exposure to polycyclic aromatic hydrocarbons. Cancer Causes Control. 1997;8:444-72.
58. Gammon MD, Santella RM. PAH, genetic susceptibility and breast cancer risk: an update from the long island breast cancer study project. Eur J Cancer. 2008;44:636-40.
59. Plaskon LA, Penson DF, Vaughan TL, Stanford JL. Cigarette smoking and risk of prostate cancer in middle-aged men. Cancer Epidemiol Biomarkers Prev. 2003;12:604-9.
60. Kooiman GG, Martin FL, Williams JA, Grover PL, Phillips DH, Muir GH. The influence of dietary and environmental factors on prostate cancer risk. Prostate Cancer Prostatic Dis. 2000;3:256-8.
61. Seidler A, Heiskel H, Bickeboller R, Elsner G. Association between diesel exposure at work and prostate cancer. Scand J Work Environ Health. 1998;24:486-94.
62. Cavalieri EL, Rogan EG, Li KM, Todorovic R, Ariese F, Jankowiak R, et al. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a, l]pyrene (db[a, l]p) or its metabolites and in rat mammary gland treated with db[a, l]p. Chem Res Toxicol. 2005;18:976-83.
63. Conney AH. Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes memorial lecture. Cancer Res. 1982;42:4875-917.
64. Jiang H, Shen YM, Quinn AM, Penning TM. Competing roles of cytochrome p450 1a1/1b1 and aldo-keto reductase 1a1 in the metabolic activation of (+/-)-7,8-dihydroxy-7,8-dihydro-benzo[a]pyrene in human bronchoalveolar cell extracts. Chem Res Toxicol. 2005;18:365-74.
65. Gammon MD, Sagiv SK, Eng SM, Shantakumar S, Gaudet MM, Teitelbaum SL, et al. Polycyclic aromatic hydrocarbon-DNA adducts and breast cancer: a pooled analysis. Arch Environ Health. 2004;59:640-9.
66. Hecht SS. Tobacco carcinogens, their biomarkers and tobacco-induced cancer. Nat Rev Cancer. 2003;3:733-44.
67. Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA. Environmental and chemical carcinogenesis. Semin Cancer Biol. 2004;14:473-86.
68. Pelkonen O, Nebert DW. Metabolism of polycyclic aromatic hydrocarbons: etiologic role in carcinogenesis. Pharmacol Rev. 1982;34:189-222.
69. Hatsukami DK, Benowitz NL, Rennard SI, Oncken C, Hecht SS. Biomarkers to assess the utility of potential reduced exposure tobacco products. Nicotine Tob Res. 2006;8:600-22.
70. Hecht SS, Carmella SG, Yoder A, Chen M, Li ZZ, Le C, et al. Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarkers Prev. 2006;15:1805-11.
71. Kuljukka-Rabb T, Nylund L, Vaaranrinta R, Savela K, Mutanen P, Veidebaum T, et al. The effect of relevant genotypes on PAH exposure-related biomarkers. J Expo Anal Environ Epidemiol. 2002;12:81-91.
72. Cancer IAfRo. Polynuclear aromatic hydrocarbons, part 2, carbon blacks, mineral oils (lubricant base oils and derived products) and some nitroarenes. IARC Monogr Eval Carcinog Risk Chem Hum. 1984;33:1-222.
73. Straif K, Baan R, Grosse Y, Secretan B, El Ghissassi F, Cogliano V. Carcinogenicity of polycyclic aromatic hydrocarbons. Lancet Oncol. 2005;6:931-2.
74. 3rd Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287:1132-41.
75. Dockery DW, 3rd Pope CA, Xu X, Spengler JD, Ware JH, Fay ME, et al. An association between air pollution and mortality in six U.S. cities. N Engl J Med. 1993;329:1753-9.
76. Brown SK. Volatile organic pollutants in new and established buildings in Melbourne, Australia. Indoor Air. 2002;12:55-63.
77. Guo H, Lee SC, Chan LY, Li WM. Risk assessment of exposure to volatile organic compounds in different indoor environments. Environ Res. 2004;94:57-66.
78. Shah JJ, Singh HB. Distribution of volatile organic chemicals in outdoor and indoor air: a National VOCs data base. Environ Sci Technol. 1988;22:1381-8.
79. Hodgson AT, Rudd AF, Beal D, Chandra S. Volatile organic compound concentrations and emission rates in new manufactured and site-built houses. Indoor Air. 2000;10:178-92.
80. Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC Monogr Eval Carcinog Risks Hum 2006;88:1-478.
81. Hansen J, Olsen JH. Formaldehyde and cancer morbidity among male employees in Denmark. Cancer Causes Control. 1995;6:354-60.
82. Hauptmann M, Lubin JH, Stewart PA, Hayes RB, Blair A. Mortality from solid cancers among workers in formaldehyde industries. Am J Epidemiol. 2004;159:1117-30.
83. Stellman SD, Demers PA, Colin D, Boffetta P. Cancer mortality and wood dust exposure among participants in the American Cancer Society Cancer Prevention Study-II (CPS-II). Am J Ind Med. 1998;34:229-37.
84. Bolt HM. Experimental toxicology of formaldehyde. J Cancer Res Clin Oncol. 1987;113:305-9.
85. Casanova M, Morgan KT, Gross EA, Moss OR, Heck HA. DNA-protein cross-links and cell replication at specific sites in the nose of F344 rats exposed subchronically to formaldehyde. Fundam Appl Toxicol. 1994;23:525-36.
86. Im H, Oh E, Mun J, Khim JY, Lee E, Kang HS, et al. Evaluation of toxicological monitoring markers using proteomic analysis in rats exposed to formaldehyde. J Proteome Res. 2006;5:1354-66.
87. Wang B, Liu DD. Detection of formaldehyde induced developmental toxicity assessed with single cell gel electrophoresis. Fen Zi Xi Bao Sheng Wu Xue Bao. 2006;39:462-6.
88. Dallas CE, Scott MJ, Ward Jr JB, Theiss JC. Cytogenetic analysis of pulmonary lavage and bone marrow cells of rats after repeated formaldehyde inhalation. J Appl Toxicol. 1992;12:199-203.
89. Kitaeva LV, Kitaev EM, Pimenova MN. The cytopathic and cytogenetic sequelae of chronic inhalational exposure to formaldehyde on female germ cells and bone marrow cells in rats. Tsitologiia. 1990;32:1212-6.
90. Zhang L, Tang X, Rothman N, Vermeulen R, Ji Z, Shen M, et al. Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev. 2010;19:80-8.
91. Hayes RB, Yin SN, Dosemeci M, Li GL, Wacholder S, Travis LB, et al. Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive MedicineNational Cancer Institute Benzene Study Group. J Natl Cancer Inst. 1997;89:1065-71.
92. Powley MW, Carlson GP. Cytochromes p450 involved with benzene metabolism in hepatic and pulmonary microsomes. J Biochem Mol Toxicol. 2000;14:303-9.
93. Beach J, Burstyn I. Cancer risk in benzene exposed workers. Occup Environ Med. 2006;63:71-2.
94. Mehlman MA. Dangerous and cancer-causing properties of products and chemicals in the oil refining and petrochemical industries. Part XXX: causal relationship between chronic myelogenous leukemia and benzene-containing solvents. Ann N Y Acad Sci. 2006;1076:110-9.
95. Vlaanderen J, Lan Q, Kromhout H, Rothman N, Vermeulen R. Occupational benzene exposure and the risk of lymphoma subtypes: a meta-analysis of cohort studies incorporating three study quality dimensions. Environ Health Perspect. 2011;119:159-67.
96. Costantini AS, Gorini G, Consonni D, Miligi L, Giovannetti L, Quinn M. Exposure to benzene and risk of breast cancer among shoe factory workers in Italy. Tumori. 2009;95:8-12.
97. Bassil KL, Vakil C, Sanborn M, Cole DC, Kaur JS, Kerr KJ. Cancer health effects of pesticides: systematic review. Can Fam Physician. 2007;53:1704-11.
98. Dich J, Zahm SH, Hanberg A, Adami HO. Pesticides and cancer. Cancer Causes Control. 1997;8:420-43.
99. Eriksson M, Hardell L, Carlberg M, Akerman M. Pesticide exposure as risk factor for non-Hodgkin lymphoma including histopathological subgroup analysis. Int J Cancer. 2008;123:1657-63.
100. Samanic CM, De Roos AJ, Stewart PA, Rajaraman P, Waters MA, Inskip PD. Occupational exposure to pesticides and risk of adult brain tumors. Am J Epidemiol. 2008;167:976-85.
101. Van Maele-Fabry G, Libotte V, Willems J, Lison D. Review and meta-analysis of risk estimates for prostate cancer in pesticide manufacturing workers. Cancer Causes Control. 2006;17:353-73.
102. Koutros S, Alavanja MC, Lubin JH, Sandler DP, Hoppin JA, Lynch CF, et al. An update of cancer incidence in the agricultural health study. J Occup Environ Med. 2010;52:1098-105.
103. Hayes RB. The carcinogenicity of metals in humans. Cancer Cause Control. 1997;8:371-85.
104. Hamilton JW, Kaltreider RC, Bajenova OV, Ihnat MA, McCaffrey J, Turpie BW, et al. Molecular basis for effects of carcinogenic heavy metals on inducible gene expression. Environ Health Perspect. 1998;106:1005-15.
105. Straif K, Benbrahim-Tallaa L, Baan R, Grosse Y, Secretan B, El Ghissassi F, et al. A review of human carcinogens - part C: metals, arsenic, dusts, and fibres. Lancet Oncol. 2009;10:453-4.
106. Hughes MF, Beck BD, Chen Y, Lewis AS, Thomas DJ. Arsenic exposure and toxicology: a historical perspective. Toxicol Sci. 2011;123:305-32.
107. Kapaj S, Peterson H, Liber K, Bhattacharya P. Human health effects from chronic arsenic poisoning - a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2006;41:2399-428.
108. Paterson RR, Lima N. Toxicology of mycotoxins. EXS. 2010;100:31-63.
109. Meggs WJ. Epidemics of mold poisoning past and present. Toxicol Ind Health. 2009;25:571-6.
110. Kensler TW, Roebuck BD, Wogan GN, Groopman JD. Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. Toxicol Sci. 2011;120:S28-48.
111. Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010;31:71-82